Pyrrole derivatives
US-9221756-B2 · Dec 29, 2015 · US
US9428494B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9428494-B2 |
| Application number | US-51309307-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 2, 2007 |
| Priority date | Nov 2, 2006 |
| Publication date | Aug 30, 2016 |
| Grant date | Aug 30, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel compounds of formula I: that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. Compounds of the invention are useful to modulate (e.g. agonize or antagonize) opioid receptor function.
Opening claim text (preview).
What is claimed is: 1. A compound which is a compound of formula 1 or 2: or a salt thereof. 2. A compound which is a compound of formula 9 or 10:
Opioid-abuse · CPC title
Alcohol-abuse · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.